Piet Vercauter

Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests

Marko Topalovic, Nilakash Das, Pierre‐Régis Burgel et al. · European Respiratory Journal · 2019 · 245 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

Martin Schüler, James Chih‐Hsin Yang, K. Park et al. · Annals of Oncology · 2015 · 132 citations · Full text

Medicine, Oncology, Pharmacology +13

Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R

Andrea Riccardo Filippi, Jair Bar, Christos Chouaid et al. · ESMO Open · 2024 · 50 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitals

Kurt G. Tournoy, Michiel Thomeer, Paul Germonpré et al. · Lung Cancer · 2017 · 44 citations

Medicine, Oncology, Pharmacotherapy +10

The genomic landscape of nonsmall cell lung carcinoma in never smokers

Bram Boeckx, Rajendra Bahadur Shahi, Dominiek Smeets et al. · International Journal of Cancer · 2019 · 43 citations · Full text

Life Sciences, Genetics, Oncology +17